Company introduction
Our company operates at the intersection of biotechnology and the health industry. Since founding the Qinling Research Institute in 2010, we have grown into an integrated enterprise spanning research and development, production, sales, contract manufacturing, and international trade. A stable and experienced core team has laid a solid foundation for our long term development. In 2012, drawing on the rich medicinal material production resources of Ning County, Qingyang City, Gansu Province, we established and opened our own factory. There we built a modern production system and a professional quality inspection platform, enabling us to source raw materials locally and control quality across the entire process. Throughout our growth, we have consistently fulfilled our social responsibilities by creating large numbers of jobs, raising incomes for surrounding farmers, contributing taxes to the region, and effectively driving regional economic development. Starting in 2014, we focused on dual purpose extracts for both food and medicinal use and expanded our OEM contract manufacturing services. In 2015, we opened a sales branch in Xi'an, built a nationwide marketing network, and operated multiple sales platforms across the value chain. As a certified premium supplier, we further strengthened our market competitiveness. In 2016, we set up a raw material direct supply base in southern Shaanxi and independently developed a digital supply chain system, achieving traceability across the entire process and noticeably improving both operational efficiency and customer repurchase rates. Over the years we have grown steadily and reached meaningful milestones. In 2017, our sales surpassed 50 million yuan. In 2018, we launched our foreign trade business on Alibaba International Station and entered a research and production partnership with Shaanxi Normal University. Since then, we have continued to optimize our raw material supply chain and extend our industrial chain, setting up several subsidiaries that cover sectors such as cosmetic raw materials and the deep processing of Ningxia goji berries, and thereby broadening our business footprint. In 2022, our sales exceeded 120 million yuan, and we deepened our research and development innovation in collaboration with Jiangnan University. In 2024, we completed a warehouse center at Xi'an Airport to upgrade our logistics system, and our foreign trade exports topped 5 million US dollars. In 2025, we invested 80 million yuan to begin construction of the Jingbian factory in northern Shaanxi. The project is dedicated to the deep processing and industrialization of traditional Chinese medicinal materials. The move is designed to further strengthen our strategic presence in the northwest region and to stimulate local employment and industrial upgrading. After more than ten years of focused development, the company has built a complete industrial chain that spans raw material cultivation, research and development, production, sales, international trade, and OEM services. Backed by comprehensive hardware facilities, strong technical capabilities, a mature operating system, and a steadfast commitment to social responsibility, we are steadily advancing toward scaled, international, and diversified growth.
Company video
R&D Capacity
- Customization Options
- Customization from Samples, Customization from Designs, Full Customization, Minor Customization, Flexible customization
- ODM Service Available
- Yes
- OEM Service Available
- Yes
Trade Capacity
- Export Year
- Own rich exporting experience
- Main Markets
- Europe, Southeast Asia/ Mideast
- Nearest Port
- Shanghai Port
- Terms of Payment
- LC, T/T, D/P, PayPal, Western Union
- Average Lead Time
- Peak Season Lead Time: within 15 workdays Off Season Lead Time: within 15 workdays
- Overseas Agent/Branch
- No
- Supply Chain Partners
- 20
- Minimum Order Quantity
- 1 KG
- International Commercial Terms(Incoterms)
- FOB, CIF, CFR, EXW
General Information
- Address
- Xi'an, Shaanxi, China
- Plant Area
- 100 square meters
- Main Products
- Plant Extracts; Active Pharmaceutical Ingredient; Cosmetics Ingredients; Veterinary Drug; Organic Chemicals; OEM Products
- Registered Capital
- 10,000,000 RMB
- Repeat Buyers Choice
- 80%~100%
- Cooperated with Fortune 500
- No